NO176868C - Fremgangsmåte ved fremstilling av et fast syrenöytraliserende preparat med forlenget oppholdstid i mavesekken - Google Patents

Fremgangsmåte ved fremstilling av et fast syrenöytraliserende preparat med forlenget oppholdstid i mavesekken

Info

Publication number
NO176868C
NO176868C NO891641A NO891641A NO176868C NO 176868 C NO176868 C NO 176868C NO 891641 A NO891641 A NO 891641A NO 891641 A NO891641 A NO 891641A NO 176868 C NO176868 C NO 176868C
Authority
NO
Norway
Prior art keywords
preparation
residence time
stomach
solid acid
acid neutralizing
Prior art date
Application number
NO891641A
Other languages
English (en)
Norwegian (no)
Other versions
NO176868B (no
NO891641L (no
NO891641D0 (no
Inventor
Robert G W Spickett
Jose Luis Fabregas Vidal
Juan Cuala Escoi
Original Assignee
Walton Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Walton Sa filed Critical Walton Sa
Publication of NO891641D0 publication Critical patent/NO891641D0/no
Publication of NO891641L publication Critical patent/NO891641L/no
Publication of NO176868B publication Critical patent/NO176868B/no
Publication of NO176868C publication Critical patent/NO176868C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08—Oxides; Hydroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Inorganic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
NO891641A 1988-04-21 1989-04-20 Fremgangsmåte ved fremstilling av et fast syrenöytraliserende preparat med forlenget oppholdstid i mavesekken NO176868C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888809421A GB8809421D0 (en) 1988-04-21 1988-04-21 Antacid compositions with prolonged gastric residence time

Publications (4)

Publication Number Publication Date
NO891641D0 NO891641D0 (no) 1989-04-20
NO891641L NO891641L (no) 1989-10-23
NO176868B NO176868B (no) 1995-03-06
NO176868C true NO176868C (no) 1995-06-14

Family

ID=10635574

Family Applications (1)

Application Number Title Priority Date Filing Date
NO891641A NO176868C (no) 1988-04-21 1989-04-20 Fremgangsmåte ved fremstilling av et fast syrenöytraliserende preparat med forlenget oppholdstid i mavesekken

Country Status (19)

Country Link
US (1) US5288506A (ja)
EP (1) EP0338861B1 (ja)
JP (1) JPH0764724B2 (ja)
KR (1) KR950007205B1 (ja)
AT (1) ATE84708T1 (ja)
AU (1) AU616257B2 (ja)
CA (1) CA1336495C (ja)
DE (1) DE68904459T2 (ja)
DK (1) DK188489A (ja)
ES (1) ES2044099T3 (ja)
FI (1) FI98886C (ja)
GB (1) GB8809421D0 (ja)
GR (1) GR3006908T3 (ja)
HU (1) HU211236A9 (ja)
IE (1) IE61866B1 (ja)
NO (1) NO176868C (ja)
NZ (1) NZ228836A (ja)
PT (1) PT90328B (ja)
ZA (1) ZA892920B (ja)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0578732B1 (en) * 1991-04-04 1996-06-19 The Procter & Gamble Company Chewable antacid compositions
FR2677546B1 (fr) * 1991-06-12 1994-01-21 Fabienne Joanny Composition therapeutique pour liberation prolonge de magnesium.
GB9310412D0 (en) * 1993-05-20 1993-07-07 Danbiosyst Uk Nasal nicotine system
US5622980A (en) * 1993-08-17 1997-04-22 Applied Analytical Industries, Inc. Oral compositions of H2-antagonists
DE4415999A1 (de) * 1994-05-06 1995-11-09 Bolder Arzneimittel Gmbh Magensäurebindende Kaupastillen
AU2576295A (en) * 1994-06-06 1996-01-04 Yamanouchi Pharmaceutical Co., Ltd. Solid antacid and process for producing the same
US6306828B1 (en) * 1995-04-06 2001-10-23 Baxter International, Inc. Enantiomerically-enhanced nutritional energy substrates
EP0867191A4 (en) * 1995-11-27 2000-01-05 Yamanouchi Pharma Co Ltd MEDICINE COMPOSITION
US6645988B2 (en) * 1996-01-04 2003-11-11 Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US6699885B2 (en) 1996-01-04 2004-03-02 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and methods of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
SE9600071D0 (sv) 1996-01-08 1996-01-08 Astra Ab New oral formulation of two active ingredients I
US6174548B1 (en) 1998-08-28 2001-01-16 Andrx Pharmaceuticals, Inc. Omeprazole formulation
US6096340A (en) * 1997-11-14 2000-08-01 Andrx Pharmaceuticals, Inc. Omeprazole formulation
US6733778B1 (en) 1999-08-27 2004-05-11 Andrx Pharmaceuticals, Inc. Omeprazole formulation
FR2793688B1 (fr) * 1999-05-21 2003-06-13 Ethypharm Lab Prod Ethiques Microgranules gastroproteges, procede d'obtention et preparations pharmaceutiques
ATE297433T1 (de) 1999-07-22 2005-06-15 Warner Lambert Co Filmbildende zusammensetzungen aus pullulan
US6262086B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Pharmaceutical unit dosage form
US6312723B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Pharmaceutical unit dosage form
US6369087B1 (en) 1999-08-26 2002-04-09 Robert R. Whittle Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6312712B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Method of improving bioavailability
US6780880B1 (en) * 1999-08-26 2004-08-24 Robert R. Whittle FT-Raman spectroscopic measurement
US6326384B1 (en) 1999-08-26 2001-12-04 Robert R. Whittle Dry blend pharmaceutical unit dosage form
US6268385B1 (en) 1999-08-26 2001-07-31 Robert R. Whittle Dry blend pharmaceutical formulations
US6262085B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6316020B1 (en) 1999-08-26 2001-11-13 Robert R. Whittle Pharmaceutical formulations
EP1245227A1 (en) * 2001-03-31 2002-10-02 Jagotec Ag A pharmaceutical tablet system that floats in the stomach for programmed release of active substance and process of producing buoyant material contained in same
SE0101379D0 (sv) 2001-04-18 2001-04-18 Diabact Ab Komposition som hämmar utsöndring av magsyra
CA2472103A1 (en) * 2002-01-25 2003-08-07 Santarus, Inc. Transmucosal delivery of proton pump inhibitors
SE0203065D0 (sv) 2002-10-16 2002-10-16 Diabact Ab Gastric acid secretion inhibiting composition
EP1603537A4 (en) * 2003-02-20 2009-11-04 Santarus Inc IMMEDIATE RELEASE OF OMEPRAZOLE ANTACIDAL COMPLEX WITH NEW FORMULATION FOR RAPID AND PROLONGED ELIMINATION OF GASTRIC ACID
US20050220870A1 (en) * 2003-02-20 2005-10-06 Bonnie Hepburn Novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid
US8993599B2 (en) * 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
AU2004257864A1 (en) * 2003-07-18 2005-01-27 Santarus, Inc. Pharmaceutical formulation and method for treating acid-caused gastrointestinal disorders
JP2006528181A (ja) * 2003-07-18 2006-12-14 サンタラス インコーポレイティッド 酸分泌を阻害するために有用な薬学的製剤ならびにそれらを作製および使用する方法
US20070292498A1 (en) * 2003-11-05 2007-12-20 Warren Hall Combinations of proton pump inhibitors, sleep aids, buffers and pain relievers
US8906940B2 (en) * 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8815916B2 (en) * 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
JP2006131581A (ja) * 2004-11-09 2006-05-25 Kyowa Chem Ind Co Ltd 崩壊剤及びこれを含有する崩壊性成形物
EP2026768B1 (en) * 2006-06-01 2018-02-28 Dexcel Pharma Technologies Ltd. Multiple unit pharmaceutical formulation
US20090092658A1 (en) * 2007-10-05 2009-04-09 Santarus, Inc. Novel formulations of proton pump inhibitors and methods of using these formulations
RS54024B1 (en) 2012-10-12 2015-10-30 Omya International Ag GASTRORETENCY FORMULATION OF MEDICINES AND SYSTEMS FOR DELIVERY AND METHODS OF THEIR PREPARATION USING FUNCTIONALIZED CALCIUM CARBONATE
EP3034070A1 (en) 2014-12-18 2016-06-22 Omya International AG Method for the production of a pharmaceutical delivery system
EP3069713A1 (en) 2015-03-20 2016-09-21 Omya International AG Dispersible dosage form
US20170042806A1 (en) 2015-04-29 2017-02-16 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
CA2898600A1 (en) * 2015-07-28 2017-01-28 Jayson King Stuffing box containment apparatus
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
EP3269361A1 (en) 2016-07-14 2018-01-17 Omya International AG Dosage form
CN110327370B (zh) * 2019-04-16 2021-02-23 马德君 阴离子黏土用于制备驱铅药物的用途
CN110780063A (zh) * 2019-12-10 2020-02-11 无锡市尚沃医疗电子股份有限公司 一种呼气氨检测方法和装置

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1416304A (fr) * 1961-10-10 1965-11-05 Smith Kline French Lab Perfectionnements apportés aux tablettes et comprimés renfermant une importante quantité d'ingrédient actif libéré pendant un laps de temps prolongé, et aux procédés pour leur préparation
CA948107A (en) * 1970-04-28 1974-05-28 Robert S. Joslin Coated antacid compositions of improved taste
US4101650A (en) * 1977-04-06 1978-07-18 Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai Pepstatin floating minicapsules
HU179474B (en) * 1978-02-24 1982-10-28 Laszlo Gyarmati Process for preparing solid oral pharmaceutical compositons with increased length of activity and with a regulated release of the active material
MTP930B (en) * 1982-04-30 1984-04-10 Delandale Labs Ltd Substained release lithium-containing tablets and method for their manufacture
US4605551A (en) * 1984-11-30 1986-08-12 William H. Rorer, Inc. Dry oil coated antacid process
US4778676A (en) * 1985-12-20 1988-10-18 Warner-Lambert Company Confectionery delivery system for actives
JPS62195323A (ja) * 1986-02-24 1987-08-28 Eisai Co Ltd 胃内滞留型粒子
GB2201594B (en) * 1986-06-24 1991-02-13 Istvan Racz Production of acid binding pharmaceutical preparations

Also Published As

Publication number Publication date
AU3317589A (en) 1989-10-26
CA1336495C (en) 1995-08-01
FI98886B (fi) 1997-05-30
US5288506A (en) 1994-02-22
JPH0764724B2 (ja) 1995-07-12
ATE84708T1 (de) 1993-02-15
DE68904459T2 (de) 1993-05-13
GR3006908T3 (ja) 1993-06-30
DK188489A (da) 1989-10-23
GB8809421D0 (en) 1988-05-25
DK188489D0 (da) 1989-04-19
PT90328B (pt) 1994-11-30
IE891282L (en) 1989-10-21
PT90328A (pt) 1989-11-10
EP0338861A2 (en) 1989-10-25
NZ228836A (en) 1990-09-26
FI98886C (fi) 1997-09-10
IE61866B1 (en) 1994-11-30
FI891896A0 (fi) 1989-04-20
KR890015733A (ko) 1989-11-25
EP0338861A3 (en) 1990-09-19
EP0338861B1 (en) 1993-01-20
ES2044099T3 (es) 1994-01-01
AU616257B2 (en) 1991-10-24
HU211236A9 (en) 1995-11-28
DE68904459D1 (de) 1993-03-04
NO176868B (no) 1995-03-06
NO891641L (no) 1989-10-23
JPH0215025A (ja) 1990-01-18
ZA892920B (en) 1989-12-27
FI891896A (fi) 1989-10-22
KR950007205B1 (ko) 1995-07-04
NO891641D0 (no) 1989-04-20

Similar Documents

Publication Publication Date Title
NO176868C (no) Fremgangsmåte ved fremstilling av et fast syrenöytraliserende preparat med forlenget oppholdstid i mavesekken
ATE74513T1 (de) Stabilisierte arzneistoffe, verfahren zu ihrer herstellung sowie stabile arzneizubereitungen.
DK0443572T3 (da) Coatinger til stabile præparater med forsinket frigivelse
PT89260A (pt) Processo de preparacao de uma composicao farmaceutica granular a base de cimetidina e de comprimidos a partir daquela
AU560829B2 (en) Continuous release pharmaceutical compositions
NO176232C (no) Fremgangsmåte for fremstilling av en fast, oral doseringsform med regulert frigivelse av medikament
IE871203L (en) Formulations containing unsaturated fatty acids
ES2018952A6 (es) Procedimiento de preparacion de composiciones antiacidas con tiempo prolongado de permanencia gastrica.
NO177484C (no) Fremgangsmåte for fremstilling av et farmasöytisk preparat i form av myke kapsler
JPS5612318A (en) Agent for suppressing oxidation of lipid
IL86169A0 (en) Substituted quinoxalyl-imidazolidine-2,4-diones,processes for their preparation and pharmaceutical compositions containing them
JPS5626910A (en) Preparation of slow-release anticancer complex composition
JPS5392768A (en) Cyclopropanecarboxylic acid esters, process for their preparation and insecticides and miticides containing the same
JPS5767523A (en) Base for pharmaceutical or cosmetic
JPS5340761A (en) Preparation of unsaturated imide amides
NO903994D0 (no) Fremgangsmaate for fremstilling av 5-aroyl-1,2-dihydro-3h-pyrrolo-(1,2-a)-pyrrol-1-carboxylsyrer og alkylestere og salter derav.